NDC 25021-119

Cefuroxime sodium

Cefuroxime Sodium

Cefuroxime sodium is a Intravenous Injection, Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Sagent Pharmaceuticals. The primary component is Cefuroxime Sodium.

• Product ID: 25021-119_42302821-15bb-4b2c-9e3d-1f2eabc795d8
• NDC: 25021-119
• Product Type: Human Prescription Drug
• Proprietary Name: Cefuroxime sodium
• Generic Name: Cefuroxime Sodium
• Dosage Form: Injection, Powder, For Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2016-09-01
• Marketing Category: ANDA / ANDA
• Application Number: ANDA064125
• Labeler Name: Sagent Pharmaceuticals
• Substance Name: CEFUROXIME SODIUM
• Active Ingredient Strength: 2 g/16mL
• Pharm Classes: Cephalosporin Antibacterial [EPC],Cephalosporins [CS]
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 25021-119-20

25 VIAL in 1 CARTON (25021-119-20) > 16 mL in 1 VIAL

• Marketing Start Date: 2016-09-01
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 25021-119-20 [25021011920]

Cefuroxime sodium INJECTION, POWDER, FOR SOLUTION

• Marketing Category: ANDA
• Application Number: ANDA064125
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2016-09-01

Drug Details

Active Ingredients

Ingredient	Strength
CEFUROXIME SODIUM	1.5 g/16mL

OpenFDA Data

• SPL SET ID: 0a145288-733a-4966-b7ae-dc96eb103d8c
• Manufacturer:
  • Sagent Pharmaceuticals
• UNII:
  • R8A7M9MY61
• RxNorm Concept Unique ID - RxCUI:
  • 1665444
  • 1665449

Pharmacological Class

• Cephalosporin Antibacterial [EPC]
• Cephalosporins [CS]
• Cephalosporin Antibacterial [EPC]
• Cephalosporins [CS]

NDC Crossover Matching brand name "Cefuroxime sodium" or generic name "Cefuroxime Sodium"

NDC	Brand Name	Generic Name
25021-118	Cefuroxime sodium	Cefuroxime sodium
25021-119	Cefuroxime sodium	Cefuroxime sodium
25021-182	Cefuroxime sodium	Cefuroxime sodium
25021-183	Cefuroxime sodium	Cefuroxime sodium